Frances Lasowski is a chemical engineer with expertise in biomaterials and drug delivery and training in commercialization. As former Executive Director of the C2020 Innovation Hub, she has worked for over a decade to advance mucoadhesive technologies from bench to clinic and has an extensive network of ophthalmic contacts. Frances has advanced 20/20 OptimEyes from lab proof to preclinical development, securing ~$2M in dilutive and non-dilutive funding to commercialize its mucoadhesive nanoparticles (MNP) platform. 

Heather Sheardown Ph.D. is the Dean of the Faculty of Engineering and a Professor in the Department of Chemical Engineering at McMaster University. She is also the Scientific Director of the C20/20 Innovation Hub and holds a cross-appointment with the School of Optometry at the University of Waterloo. She holds a Tier 1 Canada Research Chair in Ophthalmic Biomaterials and Drug Delivery Systems.

Renaud Jacquemart is a seasoned biopharma executive with 25 years of experience in product development, CMC strategy, and strategic commercialization. He has held leadership roles at Sanofi, Merck KGaA, and BioVectra and has guided multiple biotech startups through clinical development, partnerships, and M&A. He played a key role at Natrix Separations, a McMaster spin-off, that resulted in its acquisition by Merck KGaA. He now supports global drug development and CDMOs through his firm, Omnium Global. His experience spans therapeutics, vaccines, and drug delivery, with a focus on de-risking early-stage technologies and building scalable, investable business models.

Mike Foorer is a pharmaceutical business development consultant with more than 30 years of drug delivery experience across brand, specialty and generic companies.    Mike holds a B.Sc. from McMaster University, an MBA from Schulich School of Business at York University and a GPLLM from the Jackman Faculty of Law at the University of Toronto. 

Hunter Csetri is a strategic projects associate, supporting the company's commercialization and growth strategy. Working closely with the executive team, he evaluates market opportunities, identifies potential partners, and informs strategic decision-making to advance OptimEyes' platform and programs across multiple indications. He holds a Master of Biomedical Innovation and a B.H.Sc. in Integrated Biomedical Engineering & Health Sciences from McMaster University.

Benjamin Whitworth is a graphic designer and project manager with over 14 years of experience in the events industry, having served as Head of Creative for a leading events company in London, England, before relocating to Canada.

Alongside his role with the Faculty of Engineering at McMaster University, Ben works closely with the OptimEyes team to develop compelling visual communications, create branded assets, and translate complex processes into engaging, accessible content. He also manages the company's social media strategy and channels, ensuring consistent messaging and audience engagement across all platforms.